EP 4061369 A4 20240410 - A PHARMACEUTICAL FORM COMPRISING ACIDIC SUBSTANCE
Title (en)
A PHARMACEUTICAL FORM COMPRISING ACIDIC SUBSTANCE
Title (de)
PHARMAZEUTISCHE FORM MIT SAUREM STOFF
Title (fr)
FORME PHARMACEUTIQUE COMPRENANT UNE SUBSTANCE ACIDE
Publication
Application
Priority
- TR 201918013 A 20191119
- TR 202016210 A 20201012
- TR 2020051001 W 20201027
Abstract (en)
[origin: WO2021101483A1] The present invention relates to a pharmaceutical form comprises a core, an acidic substance having a pKa value of less than 6.65 and at least one binder wherein the core is coated with an acidic substance having a pKa value of less than 6.65 and at least one binder. The pharmaceutical form may use in a form of tablet or capsule as an acidifying agent.
IPC 8 full level
A61K 31/445 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 9/22 (2006.01); A61K 9/50 (2006.01); A61K 47/38 (2006.01); A61P 13/00 (2006.01); A61P 13/10 (2006.01)
CPC (source: EP)
A61K 9/1676 (2013.01); A61K 9/5042 (2013.01); A61K 31/445 (2013.01); A61P 13/00 (2018.01); A61P 13/10 (2018.01)
Citation (search report)
- [Y] CN 102579404 A 20120718 - GUANGZHOU COREDES PHARMACEUTICAL TECHNOLOGY CO LTD
- [XY] CN 103417544 A 20131204 - XINKAI MEDICAL CHEMICAL INTERMEDIATES SHANGHAI CO LTD, et al
- [XY] CN 104546782 A 20150429 - NANJING KEKANG BIOTECHNOLOGY CO LTD
- [XY] EP 2588090 B1 20170419 - KRKA TOVARNA ZDRAVIL D D NOVO MESTO [SI]
- See also references of WO 2021101483A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2021101483 A1 20210527; CA 3162409 A1 20210527; EP 4061369 A1 20220928; EP 4061369 A4 20240410
DOCDB simple family (application)
TR 2020051001 W 20201027; CA 3162409 A 20201027; EP 20889151 A 20201027